PAM
RPTP

Princeton Alpha Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Princeton Alpha Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,459
Closed -$94K – 1014
2016
Q3 		$94K Sell
10,459
-3,070
-23% -$21.8K 0.02% 711
2016
Q2 		$73K Buy
+13,529
New +$69.4K 0.01% 739

Princeton Alpha Management's RPTP Position: Q4 2016 in Review

Princeton Alpha Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 10,459 shares — an estimated $94K sold.

Princeton Alpha Management first reported a position in RPTP in Q2 2016 and held it in 2 quarters. The position peaked at $94K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Princeton Alpha Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 10,459 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $94K.
  • Princeton Alpha Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2016 and held it in 2 quarters.
  • Princeton Alpha Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $94K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Princeton Alpha Management's 13F filing for Q4 2016, filed 10 Feb 2017.